Chern-En Chiang Selected Research

Valsartan Drug Combination Amlodipine

10/2020

Amlodipine/valsartan fixed-dose combination treatment in the management of hypertension: A double-blind, randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chern-En Chiang Research Topics

Disease

32	Atrial Fibrillation 05/2024 - 12/2002
30	Heart Failure 01/2024 - 08/2012
28	Stroke (Strokes) 01/2023 - 08/2012
20	Hemorrhage 12/2022 - 02/2014
15	Hypertension (High Blood Pressure) 10/2022 - 10/2006
15	Ischemic Stroke 10/2022 - 10/2012
10	Type 2 Diabetes Mellitus (MODY) 04/2024 - 11/2007
10	Myocardial Infarction 01/2023 - 10/2012
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 01/2016
8	Coronary Disease (Coronary Heart Disease) 10/2022 - 02/2014
7	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 11/2007
7	Acute Coronary Syndrome 10/2023 - 01/2019
6	Hypercholesterolemia 04/2019 - 03/2008
5	Body Weight (Weight, Body) 11/2022 - 10/2010
5	Tachycardia (Tachyarrhythmias) 09/2011 - 01/2003
4	Embolism (Embolus) 10/2022 - 04/2018
4	Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome) 02/2013 - 02/2004
3	Diabetes Mellitus 10/2023 - 02/2014
3	Thrombosis (Thrombus) 10/2023 - 11/2007
3	Chronic Renal Insufficiency 04/2020 - 01/2015
3	Thromboembolism 01/2020 - 07/2013
2	Heart Diseases (Heart Disease) 05/2024 - 01/2022
2	Cognitive Dysfunction 05/2024 - 01/2021
2	Dementia (Dementias) 05/2024 - 10/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 10/2022
2	Cardiomyopathies (Cardiomyopathy) 10/2022 - 06/2021
2	Frailty 10/2022 - 01/2022
2	Unstable Angina 10/2022 - 01/2020
2	Essential Hypertension 01/2021 - 10/2006
2	Neoplasms (Cancer) 10/2020 - 09/2013
2	Hemorrhagic Stroke 01/2019 - 08/2017
2	Proteinuria 05/2017 - 01/2015
2	Venous Thromboembolism 01/2017 - 01/2016
2	Cardiac Arrhythmias (Arrythmia) 05/2013 - 05/2007
2	Atrioventricular Nodal Reentry Tachycardia (AV Nodal Reentrant Tachycardia) 02/2013 - 02/2005
2	Ventricular Tachycardia 10/2004 - 10/2003
2	Shock 04/2004 - 12/2002
1	Insulin Resistance 04/2024
1	Diabetic Cardiomyopathies 04/2024
1	Liver Diseases (Liver Disease) 01/2024
1	Osteonecrosis (Kienbock's Disease) 10/2023
1	Arthralgia (Joint Pain) 10/2023
1	Breast Neoplasms (Breast Cancer) 10/2023
1	Overweight 10/2023
1	Obesity 10/2023
1	Inflammation (Inflammations) 01/2023

Drug/Important Bio-Agent (IBA)

30	AnticoagulantsIBA 05/2024 - 08/2012
20	Vitamin K FDA Link 05/2024 - 07/2013
17	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 11/2007
14	dapagliflozinIBA 04/2024 - 11/2019
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024 - 10/2012
8	N(4)-oleylcytosine arabinosideIBA 05/2024 - 02/2015
8	omega-Chloroacetophenone (Mace)IBA 01/2023 - 10/2012
8	SodiumIBA 11/2022 - 01/2015
7	oxidized low density lipoproteinIBA 02/2024 - 08/2012
7	alirocumabIBA 10/2023 - 01/2018
5	edoxabanIBA 12/2022 - 02/2015
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
5	Dabigatran FDA Link 12/2018 - 02/2015
4	pro-brain natriuretic peptide (1-76)IBA 04/2024 - 01/2018
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 07/2014
4	RivaroxabanIBA 12/2018 - 02/2015
4	LipidsIBA 03/2017 - 03/2008
3	theasinensin AIBA 05/2024 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2013
3	apixabanIBA 12/2022 - 01/2016
3	Antihypertensive Agents (Antihypertensives)IBA 05/2022 - 10/2006
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2022 - 09/2013
3	Angiotensin Receptor AntagonistsIBA 05/2022 - 09/2013
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2022 - 10/2015
3	Sodium-Glucose Transport ProteinsIBA 01/2022 - 11/2019
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 11/2019
2	Natriuretic PeptidesIBA 05/2024 - 01/2022
2	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2024 - 01/2022
2	LDL CholesterolIBA 02/2024 - 01/2014
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2022 - 07/2020
2	SaltsIBA 01/2022 - 10/2010
2	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 10/2006
2	CholesterolIBA 03/2017 - 01/2014
2	Rosuvastatin Calcium (Crestor)FDA Link 05/2016 - 03/2008
2	Digoxin (Digitek)FDA LinkGeneric 10/2015 - 10/2014
2	Adenosine Triphosphate (ATP)IBA 04/2004 - 12/2002
1	finerenoneIBA 05/2024
1	ALN-PCSIBA 02/2024
1	vericiguatIBA 01/2024
1	A-factor (Streptomyces)IBA 01/2024
1	Denosumab FDA Link 10/2023
1	Bone Density Conservation AgentsIBA 10/2023
1	Diphosphonates (Bisphosphonates)IBA 10/2023
1	Lipoprotein(a)IBA 10/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2023
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	Tolvaptan FDA Link 11/2022

Therapy/Procedure

29	Therapeutics 04/2024 - 12/2002
9	Catheter Ablation 05/2013 - 12/2002
3	Secondary Prevention 01/2019 - 04/2016
2	Percutaneous Coronary Intervention 01/2022 - 05/2018
2	Dental Scaling 10/2013 - 04/2013